环状RNA circ_0004535对2型糖尿病合并代谢相关脂肪性肝病模型小鼠的影响
DOI:
作者:
作者单位:

1.新疆医科大学第六附属医院;2.新疆生产建设兵团医院

作者简介:

通讯作者:

中图分类号:

基金项目:

新疆医科大学第六附属医院科研专项基金-在读博士生专项基金(LFYKYZX2023-16)


Effect of circular RNA circ_0004535 on type 2diabetes mellitus combined with metabolism-related fatty liver disease model mice
Author:
Affiliation:

1.The Sixth Affiliated Hospital of Xinjiang Medical University,Wulumuqi;2.China;3.Xinjiang Production and Construction Corps Hospital

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨 hsa_circ_0004535对2型糖尿病(T2DM)合并代谢相关脂肪性肝病(MAFLD)模型小鼠的影响。方法 于2021年9月至2022年3月。选取SPF级48只健康Balb/c小鼠进行建模并分组,每组6只,对照组:正常饲料喂养;T2DM组:高糖饮食诱导的糖尿病模型;T2DM合并MAFLD组:同时予以高脂高糖饲料,诱导糖尿病合并脂肪肝模型;T2DM合并MAFLD+hsa_circ_NC组:建模4周后,尾静脉注射10nmol/只hsa_circ_NC;T2DM合并MAFLD +hsa_circ_0004535组:建模4周后,尾静脉注射10nmol/只circ_0004535;T2DM合并MAFLD+miRNA_NC组:建模4周后,尾静脉注射10nmol/只miRNA空白对照;T2DM合并MAFLD+miR-1827agomir组:建模4周后,尾静脉注射10nmol/只miR-1827agomir;T2DM合并MAFLD+miR-1827antagomir组:建模4周后,尾静脉注射10nmol/只miR-1827antagomir。给与干预措施后每周测量体重并记录;行葡萄糖耐量和胰岛素耐受实验;测血脂、肝功;计算肝脏指数、胰岛素抵抗指数;病理学指标检(HE和油红O染色、免疫组化、TUNEL染色、Masson染色)测肝脏炎症、脂肪沉积及纤维化程度。结果 (1)注射hsa_circ_0004535组的动物体重、肝重、肝脏指数、胰岛素抵抗指数及生化指标均显著低于注射hsa_circ_NC组与T2DM合并MAFLD组(P均<0.05)。(2)HE染色示:T2DM合并MAFLD+ circ_0004535组,脂肪变性空泡减少变小,炎性细胞浸润减少。油红染色结果和HE染色结果相一致。(3)TUNEL染色示:T2DM合并MAFLD+hsa_circ_0004535组TUNEL阳性细胞明显减少(P<0.05)。(4)Masson染色示:T2DM合并MAFLD+hsa_circ_0004535组胶原纤维沉积显著减少(P<0.05)。结论 在T2DM合并MAFLD的动物模型中,hsa_circ_0004535和miRNA-1827的表达在调控脂质代谢、胰岛素敏感性、炎症通路、肝细胞凋亡、肝纤维化相关通路方面发挥着重要作用。

    Abstract:

    Objective To explore the influence of hsa_circ_0004535 on type 2 diabetes(T2DM) combined with metabolic-associated fatty liver disease(MAFLD) model mice. Methods From September 2021 to March 2022. Forty-eight healthy Balb/c mice of SPF grade were selected for modeling and grouping, control group, Each group had 6 mice.Control group: normal feed; T2DM group: diabetes model induced by high glucose diet; T2DM combined MAFLD group: high fat and high glucose feed was given at the same time to induce diabetes combined with fatty liver model; T2DM combined MAFLD + hsa_circ_NC group: after 4 weeks of modeling, 10 nmol/only hsa_circ_NC was injected into the tail vein; T2DM combined MAFLD +hsa_circ_0004535 group: after 4 weeks of modeling, 10nmol/only circ_0004535 was injected into the tail vein; T2DM combined MAFLD+miRNA_NC group: after 4 weeks of modeling, 10nmol/only miRNA blank control was injected into the tail vein; T2DM combined MAFLD+miR- 1827agomir group: after 4 weeks of modeling, 10nmol/only miR-1827agomir was injected into the tail vein; T2DM combined MAFLD+miR-1827antagomir group: after 4 weeks of modeling, 10nmol/only miR-1827antagomir was injected into the tail vein; after the interventions, body weight was measured and recorded weekly. Glucose tolerance and insulin tolerance tests were performed; blood lipids and liver function were measured; liver index and insulin resistance index were calculated; and pathological index tests (HE and oil red O staining, immunohistochemistry, TUNEL staining, Masson staining) were performed to measure the degree of hepatic inflammation, fat deposition and fibrosis. Results (1) The body weight, liver weight, liver index, insulin resistance index and biochemical indexes of the animals in the hsa_circ_0004535 injection group were significantly lower than those in the hsa_circ_NC injection group and the T2DM combined MAFLD group (both P < 0.05). (2) HE staining showed that in the T2DM combined MAFLD+ circ_0004535 group, the steatosis vacuoles were reduced and smaller, and the inflammatory cell infiltration was reduced. The results of oil red staining were consistent with those of HE staining. (3) TUNEL staining showed that TUNEL-positive cells were significantly reduced in the T2DM combined MAFLD+hsa_circ_0004535 group (P < 0.05). (4) Masson staining showed that collagen fiber deposition was significantly reduced in the T2DM combined MAFLD+hsa_circ_0004535 group (P < 0.05).Conclusion The expression of hsa_circ_0004535 and miRNA-1827 plays an important role in regulating lipid metabolism, insulin sensitivity, inflammatory pathways, hepatocyte apoptosis, and hepatic fibrosis-related pathways in the animal model of T2DM combined with MAFLD.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-02-12
  • 最后修改日期:2025-04-19
  • 录用日期:2025-06-27
  • 在线发布日期:
  • 出版日期: